Results 171 to 180 of about 1,760,646 (211)

The Use of Moxifloxacin for Acute Exacerbations of Chronic Obstructive Pulmonary Disease and Chronic Bronchitis

Expert Review of Respiratory Medicine, 2012
Chronic obstructive pulmonary disease is a common condition which causes considerable morbidity and mortality. It is a heterogenous disorder in which the majority of patients have chronic bronchitis. Bacterial infections are a major cause of acute exacerbations of both conditions which have a major impact on healthcare resources, quality of life and ...
Robert, Wilson, Aislinn, Macklin-Doherty
exaly   +3 more sources

Acute laryngeal obstruction in a patient with chronic bronchitis.

European journal of anaesthesiology, 1987
An unusual case of acute respiratory obstruction due to a laryngeal cyst is described. The mixed inspiratory and expiratory nature of this obstruction is discussed, and its implications for diagnosis and anaesthetic management. Alternative forms of management, especially those of transtracheal insufflation and transtracheal ventilation, and their ...
M, Bell, L, Hasselstrøm, A, Bomholt
openaire   +1 more source

Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis

European Journal of Clinical Microbiology & Infectious Diseases, 1998
Treatments with once-daily trovafloxacin (200 or 100 mg) and amoxicillin/clavulanic acid (500/125 mg three times daily) were compared in adults with acute exacerbations of chronic obstructive bronchitis. At end of treatment, 95% (113/119) of clinically evaluable patients receiving trovafloxacin 200 mg, 98% (113/115) of patients treated with ...
P, Léophonte, R J, Baldwin, N, Pluck
openaire   +2 more sources

Management of Chronic Obstructive Pulmonary Disease Exacerbations and Acute Bronchitis

2008
Chronic obstructive pulmonary disease (COPD) affects approximately 14 million Americans and is currently the fourth leading cause of death in the United States. It is currently the only leading cause of death with an increasing mortality rate, and healthcare costs associated with the disease are estimated at 32 billion dollars per year.
openaire   +1 more source

Substantiation of tactics of antibacterial therapy in children with acute obstructive bronchitis of bacterial origin

SOVREMENNAYA PEDIATRIYA, 2015
Objective: to evaluate the clinical effectiveness of the third generation cephalosporin «Cefodox» in infants with acute obstructive bronchitis. Patients and methods. The bacteriological monitoring of 217 infants with acute obstructive bronchitis of Zaporizhzhya city and Zaporizhzhya region is carried out. Results. In 53% of cases the pathogens of acute
Lezhenko, G. A., Pashkov, E. E.
openaire   +2 more sources

A contribution to study of acute obstructive bronchitis and bronchopneumonia in infants.

Allergie und Immunologie, 1982
103 infants with acute obstructive bronchitis and/or bronchopneumonia were studied. IgM and alpha-1-antitrypsin values were determined by single radial immunodiffusion. In each infant the values were studies in eight serum samples. Comparison of the time of clinical recovery and x-ray clearing of the lung and the time of normalization of IgM and alpha ...
openaire   +1 more source

Home - About - Disclaimer - Privacy